Get updates delivered to you daily. Free and customizable.
The Associated Press
Trinity Life Sciences Announces New Customer Engagement Solutions Leveraging Its Deep Commercial Insight and Recognized Technology Platform
4 hours ago
Nancy Phelan is a recognized industry thought leader and expert in customer engagement and omnichannel, with a proven track record of pioneering digital first and data driven approaches to drive performance and achieve outcomes in life sciences. Ms. Phelan has joined Trinity Life Sciences as Senior Vice President of Customer Engagement. (Photo: Business Wire)
WALTHAM, Mass.--(BUSINESS WIRE)--Aug 21, 2024--
Trinity Life Sciences, the leader in strategy, insights and analytics for the life sciences industry, announces new Customer Engagement solutions leveraging both Trinity’s deep commercial insight and recognized technology platform. The new offerings are designed to help life sciences organizations with novel customer engagement solutions including adaptive segmentation, rep-directed guidance including target patient triggers, deep insights on healthcare provider (HCP) preferences and orchestration of activation across channels. At the helm of these new offerings is Nancy Phelan, Senior Vice President and Head of Customer Engagement.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240821127175/en/
Nancy Phelan is a recognized industry thought leader and expert in customer engagement and omnichannel, with a proven track record of pioneering digital first and data driven approaches to drive performance and achieve outcomes in life sciences. Ms. Phelan has joined Trinity Life Sciences as Senior Vice President of Customer Engagement. (Photo: Business Wire)
Ms. Phelan is a recognized industry thought leader and expert on omnichannel and customer engagement, with a proven track record of pioneering digital-first and data-driven approaches. With over 25 years of experience with companies such as Novartis, Adhera Therapeutics, Bristol Meyers Squibb and Pfizer, she brings a deep expertise in customer engagement strategy and operations, globally and in major markets across specialty and primary care. Ms. Phelan also currently sits on the boards of Medexus Pharmaceuticals and FemmePharma Consumer Healthcare.
“I’m delighted to have such a passionate, data-driven expert leading one of our most important growth pillars,” said Aparna Deshpande, Senior Partner and Head of Analytics & Insights at Trinity Life Sciences. “Nancy has been on the cutting edge of both the strategy and execution of customer engagement programs within life sciences companies and can demonstrate real-world successes that dramatically show better engagement with payers, healthcare professionals (HCPs) and patients. Our Customer Engagement offerings focus on the human beings behind the data.”
The new Trinity Customer Engagement solutions will provide life sciences executives with unparalleled thought leadership and capabilities, including proven decision intelligence, leading customer engagement expertise, a modular solution ecosystem and dynamic engagement models that enable them to gain real-world acceptance of their brands and make a difference in patients’ lives.
“It was important for me to join an organization that had the building blocks to create Customer Engagement solutions that combine strategy, insights and analytics to see connectivity across patients, physicians and payers and meaningfully help our clients achieve their commercialization ambitions,” said Nancy Phelan, SVP and Head of Customer Engagement at Trinity Life Sciences. “Trinity, with its almost 30 years’ experience in life sciences, offers expertise and sophisticated tools to allow clients to look around the corner and see what their customers need.”
Nancy Phelan Thought Leadership
Ms. Phelan will be featured in the following upcoming webinar:
Ms. Phelan will be featured in the following upcoming webinar:
Who “Owns” the Customer in Customer Engagement? – hosted by Trinity Life Sciences
October 3 at 1 PM ET
October 8 – 16:00 – 16:45 (UTC +8:00) – Asia/Shanghai
October 8 – 15:00 – 15:45 CET – Europe/Berlin
With the rising adoption of digital and virtual approaches to customer engagement, companies are facing more complexity in commercialization. Trinity’s Customer Engagement experts will discuss who “owns” the customer and how to effectively collaborate cross-functionally to drive performance. Besides Ms. Phelan, the expert panel will also include:
Kevin Francis, Partner, Customer Engagement Strategy
With almost 30 years of expertise, a best-in-the-business team and unrivaled access to data and analytics, Trinity Life Sciences is a modern partner to companies in the life sciences industry. Trinity combines strategy, insights and analytics to help life science executives with clinical and commercial decision-making. We serve over 350 pharmaceutical, biotech and medical device clients, helping them develop the right drugs and devices for today’s market and optimize them once in market. We have a diverse staff of over 1200 people and 11 global offices across the U.S., Europe and Asia. Ultimately, we know that every decision our clients make impacts a life, and when we help our clients achieve their goals, the world benefits. To learn more about how Trinity is elevating the industry and driving evidence to action, visit TrinityLifeSciences.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20240821127175/en/
CONTACT: Media:
Elizabeth Marshall
Trinity Life Sciences
emarshall@trinitylifesciences.com
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS
INDUSTRY KEYWORD: TECHNOLOGY MEDICAL DEVICES PROFESSIONAL SERVICES BIOTECHNOLOGY DATA ANALYTICS PHARMACEUTICAL HEALTH DATA MANAGEMENT SCIENCE OTHER SCIENCE
SOURCE: Trinity Life Sciences
PUB: 08/21/2024 08:37 AM/DISC: 08/21/2024 08:37 AM
Get updates delivered to you daily. Free and customizable.
It’s essential to note our commitment to transparency:
Our Terms of Use acknowledge that our services may not always be error-free, and our Community Standards emphasize our discretion in enforcing policies. As a platform hosting over 100,000 pieces of content published daily, we cannot pre-vet content, but we strive to foster a dynamic environment for free expression and robust discourse through safety guardrails of human and AI moderation.
Comments / 0